End point | Baseline correlation | Week 12 correlation | Week 24 correlation |
---|---|---|---|
DAPSA | 0.591 | 0.749 | 0.797 |
HAQ | 0.525 | 0.577 | 0.589 |
EQ-5D | −0.426 | −0.528 | −0.556 |
HADS anxiety | 0.300 | 0.314 | 0.343 |
HADS depression | 0.322 | 0.384 | 0.394 |
Subject assessment | |||
General health | 0.345 | 0.400 | 0.505 |
Arthritis | 0.294 | 0.474 | 0.530 |
Psoriasis | 0.161 | 0.351 | 0.423 |
Joint pain | 0.333 | 0.496 | 0.561 |
Swollen joint count | 0.516 | 0.565 | 0.628 |
Tender joint count | 0.564 | 0.746 | 0.801 |
PASI | 0.217 | 0.289 | 0.399 |
DLQI | 0.389 | 0.419 | 0.483 |
Enthesitis | 0.600 | 0.501 | 0.478 |
Dactylitis | 0.636 | 0.471 | 0.445 |
CRP | 0.192 | 0.145 | 0.206 |
CRP, C reactive protein; DAPSA, Disease Activity index for PSoriatic Arthritis; DLQI, Dermatology Life Quality Index; EQ-5D, EuroQol-5Day; HADS, Hospital Anxiety And Depression Scale; HAQ, Health Assessment Questionnaire; PASI, Psoriasis Area and Severity Index.